Claybrook Capital’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-16,730	Closed	-$1.45M	–	164
2021 Q2	$1.45M	Buy	+16,730	New	+$1.45M	0.47%	64